





Measurement and Estimation 
of renal function
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• How to estimate GFR?
• How to measure GFR?
• How to estimate GFR?
• How to measure GFR?
Serum creatinine
• One of the most prescribed analyte in clinical 
chemistry
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NephroTest Cohort (France)
Which GFR for patients with 
serum creatinine measured 
at 80 µmol/L (0.9 mg/dL)?
IC 95% for subjects<65 years old
IC 95% for subjects>65 years old
GFR





• Different Jaffe-Enzymatic methods, different 
calibration by different manufacturers
• Interferences
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• Tubular secretion of creatinine
10 to 40%
Increase with decreased GFR
Unpredictable at the individual level !
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Physiological limitations
• Production (relatively) constant but muscular 
production => serum creatinine is dependent of 




• Muscular mass (creatine)
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Creatinine: to the trash?
• Very cheap (0.04€ /Jaffe)
• Good specificty
• Good analytical CV
• Favor for enzymatic methods
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Creatinine clearance
• Not recommended by guidelines
• Creatinine tubular secretion
• Lack of precision: 
errors in urine collection
22 to 27% for « trained » patients
50 to 70 % for others
large intra-individual variability for 
creatinine excretion
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Creatinine-based equations
Why such equations?
• Conceptualize the hyperbolic assocation
between creatinine and GFR?
• Interpreting the result of creatinine by 
gender, age, ethnicity
























• Good correlation: a “sine qua non” condition but insufficient
• Bias: mean difference between two values = the systematic error
• Precision: SD around the bias = the random error
• Accuracy 30% = % of eGFR between ± 30% of measured GFR
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Population Canada 1976 USA 1999
N 249 1628
Mean GFR 73 40
Measured GFR Creatinine Clearance Iothalamate
Assay Jaffe (special) Jaffe calibré
% women 4 40
% black 0 (?) 12
Mean age 18-92 51
Mean weight 72 79.6
Indexation for BSA No yes
Internal validation no yes
Cockcroft DW, Nephron, 1976, 16, p31
Levey AS, Ann Intern Med, 1999, 130, p461






• Good accuracy in stage 3-4 CKD
• Best accuracy observed: 80-85%
• Better than Cockcroft especially in precision 
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MDRD: the limitations
MDRD more bias (absolute) and less precision in 
high GFR
Non negligible proportion of subjects with stage 2 
classified as stage 3 CKD
21




 Development dataset: n=5504
 Internal validation: n=2750
 External validation: n=3896
 Creatinine calibrated 
 Median GFR in the development = 68 mL/min/1.73 m²
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Discussion:
MDRD or CKD-EPI ?
• Lower CKD prevalence in epidemiological studies
• Better prediction of CVD => better at the population 
level
• Better bias in GFR >60 (90?) ml/min/1.73m² but not 
better precision => not better at the individual level
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A price to pay?
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The price to pay…
• What would be your choice?
Better estimate the GFR of a subject with
measured GFR between 90 and 120 mL/min/1.73 
m²?
Better estimate the GFR of a patient with
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• Another biomarker: cystatin C
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Schaeffner, Ann intern Med, 2012, 157, 471
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X 0.82 (if female)
• n=610, iohexol, IDMS traceable enzymatic method
• Mean = 52 mL/min/1,73 m²

• Lund-Malmo
• n=3495 (by 2847 subkects), iohexol, IDMS serum creatinine
• Mean GFR = 60 mL/min/1,73 m²
2014, 52(6), 815-824
One concept more than « regressions »…
+50%








• + for Combined, children
• “Cost-effectiveness?”





- CKD-EPI vs BIS -
• Koppe L et al. J Nephrol, 2013
• n=224, Mean Age=75            72% vs 76%
• Lopes M et al. BMC Nephrology, 2013
• n=95, Mean Age=85             75% vs 80%
• Alshoer I et al. AJKD, 2014
• n=394, Median Age=80          83% vs 88%
• Vidal-Petiot E et al. AJKD, 2014
• N=609, Mean Age=76           82% vs 84%
n=805, Mean Age=80





5 cohortes > 70 y
Creatinine
Bias: worse for CKD-EPI




No difference with creat
Combined




Limitations of eGFR = creatinine
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If creatinine is especially « bad » for reflecting GFR (most of time 
because abnormal muscular mass), your eGFR result won’t be 
accurate
Spec fic popul tion: eGFR is n  
magic!!
Keep our clinical feeling!!
Anorexia Nervosa (Delanaye P, Clin Nephrol, 2009, 71, 482)
Cirrhotic (Skluzacek PA, Am J Kidney Dis, 2003, 42, 1169)
Intensive Care (Delanaye P, BMC Nephrology, 2014, 15, 9)
Severely ill (Poggio ED, Am J Kidney Dis, 2005, 46, 242)
Heart transplanted (Delanaye P, ClinTransplant, 2006, 20, 596)
Kidney transplantation (Masson I, Transplantation, 2013, 95, 1211)
Obese (Bouquegneau A, NDT, 2013, 28, iv122)
Elderly (Schaeffner E, Ann Intern Med, 2012, 157, 471)
Hyperfiltration (Gaspari F, Kidney Int, 2013, 84, 164)
Conclusions: eGFR
a double message ?
• For General Physicians:
MDRD (or CKD-EPI or FAS) is probably 
the best and simplest way to estimate GFR
• For Nephrologists:
MDRD (or CKD-EPI) is not “magic”, keep 
our critical feeling, there are several 
limitations we have to know
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Today the true question is maybe not about which 
equation is the best 
• When is it necessary to measure GFR?
Delanaye P, Nature Rev Nephrol, 2013, 9, 513 
• How to estimate GFR?
• How to measure GFR?
• How to estimate GFR?
• How to measure GFR?
Measuring GFR: Why?
Question of precision!
• The decision to initiate dialysis
• Sarcopenic individuals 
• Extreme body size
• Cirrhosis, ICU, Hyperfiltration
• Living kidney donation
• Dosing a potentially nephrotoxic drug (=>2)
• Clinical research, EMA
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• Less precision, less repeatability (urine 
recolt!)
• Differences are systematic
Available on the market…
Markers Strenghts Limitations
Inulin
Gold standard (or historic)
Was Safe…
Costly
Dosage neither easy  nor standardized
Doubt with plasma clearance
Iothalamate
The most popular in USA
Isotopic or “cold” method
Tubular secretion
Cannot be used if allergy to iodine
Iohexol
The most popular in Europe
Cold method
Worldwide available
EDTA Easy to measure
Only isotopic
Not available in USA
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Iothalamate versus iohexol






1) Standardization for procedure
• Urinary versus plasma
• Number of samples and timing of samples
• Whatever the marker…
Delanaye P, Clin Kidney J, 2016, 9, 700
Standardization for the marker
• Only cold methods can easily be 
implemented worldwide
• Iothalamate is difficult to obtain in Europe
• Inulin is expensive and only available as 
urinary clearance (withhold in FRANCE!!)
• Iohexol is available worldwide
• Very stable (central and/or “reference” 
laboratories)
• EQUAS (Equalis, Sweden) is available!
Iohexol in CHU Liège
• Iohexol (plasma clearance), 5 mL bolus
• 5 hours
• Samples at 2, 3, 4 et 5 hours (longer if very low eGFR)
• Brochner-Mortensen
• 50 to 100 euros
Conclusions
• Measuring GFR is not so cumbersome 
• Standardization (marker, procedure and 
measurement) might still be improved
• Iohexol is the best balance between physiology 
and feasibility
• Iohexol is safe 
• Iohexol is the only chance for a worldwide 
standardized mGFR
Thank you for your attention!
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 The Cockcroft original study
 Final sample n=236
 But the starting sample was 534 with 2 available 
creatinine clearance in medical wards
 Exclusion of 56% (!) because :
1. Variability of serum creatinine > 20%: n=29
2. Creatinine excretion/24 h < 10 mg/d: n=31
3. Inadequate (?) data: n=65
4. Variability of creatinine excretion > 20%:  n=173 
(32%)
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Measurement of serum creatinine: 
analytical limitations
Urinary clearance
• Constant infusion, marker at equilibrium
• Plasma measurement of the marker
• Collect Urine (every half or every hour) and measurement of urine 
flow, urine measurement of the marker
• Repeated 3 or 4-fold 
• Cl = [U] x [V]/ [P] (mean of three collections)
Are they equivalent?
Plasmatic Clearance =  Dose / AUC
Not easy in practice (many samples)
Only slope ß after equilibrium is
calculated
Theoritically,  and  must be calculated
M
Brochner-Mortensen 
mathematical correction for 
estimation of distribution phase
= 0,990778 x C2 – 0,001218 C2²
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